Table 2. Correlation of PLIN1 expression with copy number changes in different cancer types.

Cancer type	Shallow deletiion	Diploid	Gain	p value (shallow deletion vs diploid)	p value (gain vs diploid)
Colorectal Adenocarcinoma	123	229	22	0.56	0.20
Adrenocortical Carcinoma	17	48	10	0.82	0.28
Brain Lower Grade Glioma	54	445	13	0.0003	0.006
Breast Invasive Carcinoma	270	626	147	< 0.0001	< 0.0001
Cervical Squamous Cell Carcinoma	44	175	64	0.001	0.24
Glioblastoma Multiforme	28	108	10	0.91	0.22
Esophageal Carcinoma	45	86	45	0.54	0.15
Stomach Adenocarcinoma	4	21	6	ND	ND
Uveal Melanoma	4	74	2	ND	ND
Head and Neck Squamous Cell Carcinoma	98	327	87	0.57	0.92
Kidney Renal Clear Cell Carcinoma	36	461	27	0.17	0.27
Liver Hepatocellular Carcinoma	71	247	46	< 0.0001	0.88
Lung Adenocarcinoma	210	238	60	0.0002	0.40
Lung Squamous Cell Carcinoma	104	232	151	0.03	0.09
Ovarian Serous Cystadenocarcinoma	128	113	45	0.16	0.28
Pancreatic Adenocarcinoma	29	128	14	0.002	0.004
Mesothelioma	6	64	15	ND	0.04
Prostate Adenocarcinoma	26	298	8	0.47	ND
Skin Cutaneous Melanoma	40	209	111	0.60	0.58
Sarcoma	36	125	68	< 0.0001	0.15

ND: not done, because of no cases or a small number of cases (< 10).